Related Experiment Video
Updated: Mar 25, 2026

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
8.1K
Network-Based Method for Inferring Cancer Progression at the Pathway Level from Cross-Sectional Mutation Data.
IEEE/ACM Transactions on Computational Biology and Bioinformatics
|February 26, 2016
Summary
Inferring cancer progression is challenging due to limited temporal data. A novel Network-based method (NetInf) infers mutation order at the pathway level from cross-sectional data, offering new insights into cancer development.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Large-scale cancer genomics projects generate vast somatic mutation data.
- Inferring the temporal order of mutations for cancer progression is a significant challenge due to the scarcity of longitudinal patient samples.
Purpose of the Study:
- To develop and validate a novel computational method for inferring cancer progression pathways from cross-sectional genomic data.
- To address the challenge of reconstructing the temporal order of somatic mutations across a cohort of cancer patients.
Main Methods:
- A Network-based method (NetInf) was developed to infer cancer progression at the pathway level.
- The method leverages the exclusive property of driver mutations within pathways and linear progression between pathways.
- NetInf was assessed using simulated data with varying noise levels and applied to real somatic mutation data from three cancer studies.
Main Results:
- NetInf successfully inferred cancer progression pathways from cross-sectional data.
- The identified pathways demonstrated significant biological enrichment.
- The method showed robustness against noise in simulated datasets.
Conclusions:
- NetInf provides an efficient computational approach to infer cancer progression at the pathway level.
- The method offers new insights into the temporal order of somatic mutations, moving beyond gene-level analysis.
- This approach reduces computational complexity by constructing gene networks without pre-defining the number of pathways.
Related Concept Videos
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Cancer
55.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.5K
Cancer Survival Analysis
821
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
821
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K

